Sangamo Therapeutics Inc SGMO
NAS: SGMO | ISIN: US8006771062 30/04/2025
0,772 USD (+7,04%)
(+7,04%)
30/04/2025
Profiel Sangamo Therapeutics Inc
Website: www.sangamo.com
Hoofdzetel: Brisbane, California 
Verenigde Staten
CEO: Alexander Macrae
Werknemers: 520